Webinar: A Swedish-American Journey of Innovation in Cancer Research
Welcome to a seminar focusing on the triple helix model, the Swedish teachers’ exemption, and how these frameworks spur academic innovation from the lab to bedside care. The seminar is co-hosted by the Embassy of Sweden in Washington, DC, Dana-Farber Institute of Cancer, Harvard Medical School, Uppsala University, and Oncopeptides AB.
Program (All times are EST - please add +6.00 for CET):
10:00 AM Welcome and Introduction H.E. Karin Olofsdotter, Ambassador of Sweden to the United States, and Professor Ola Landgren, MD PhD, University of Miami
10:10 AM Keynote: “Multiple Myeloma – 20 Years of Research is Transforming Patients’ Lives” Dr. Paul Richardson, RJ Corman Professor of Medicine, Harvard Medical School, Dana-Farber Cancer Institute, and Patient
10:25 AM Short Film
10:30 AM Panel Discussion: “The Swedish Innovation Model”
Moderator: Ola Landgren, MD PhD, University of Miami
Panelists: Dr. Joachim Gullbo, Associate Professor in Experimental Clinical Pharmacology, Theradex Oncology, Uppsala University, and Co-Founder and Senior R&D Strategist, Oncopeptides; Professor Mats Larhed, Vice-Rector of Disciplinary Domain of Medicine and Pharmacy, Uppsala University; and Professor Henric Johnson, Counselor, Science and Innovation, Embassy of Sweden in Washington, DC
11:00 AM Short Film
11:05 AM Panel Discussion: “Swedish-US Research Collaboration – Driving Innovation in Cancer” Moderator: Ola Landgren, MD PhD, University of Miami
Panelists: Mr. Marty J Duvall, CEO, Oncopeptides; Professor Kenneth Anderson, Kraft Family Professor of Medicine, Harvard Medical School, Dana-Farber Cancer Institute; Dr. Jenni Nordborg, Head of the Office for Life Sciences, Government Offices of Sweden;
Ms. Suzanne Håkansson, Senior Director, Governmental Affairs Europe and Nordic, AstraZeneca; and Professor Tobias Sjöblom, Department of Immunology, Genetics, and Pathology, Uppsala University
11:45 AM Concluding Remarks
12:00 PM End of Seminar
After registering, you will receive a confirmation email containing information on how to join the webinar.